EP2 Antagonists (2011–2021): A Decade’s Journey from Discovery to Therapeutics-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

EP2 Antagonists (2011–2021): A Decade’s Journey from Discovery to Therapeutics

Published:2021-08-05 Issue:16 Volume:64 Page:11816-11836
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Sluter Madison N.¹,Hou Ruida¹,Li Lexiao¹,Yasmen Nelufar¹,Yu Ying¹,Liu Jiawang¹²,Jiang Jianxiong¹^ORCID

Affiliation:

1. Department of Pharmaceutical Sciences, College of Pharmacy, University of Tennessee Health Science Center, Memphis, Tennessee 38163, United States

2. Medicinal Chemistry Core, Office of Research, University of Tennessee Health Science Center, Memphis, Tennessee 38163, United States

Funder

National Institute of Neurological Disorders and Stroke

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.1c00816

Reference222 articles.

1. CYCLOOXYGENASES 1 AND 2

2. Cyclooxygenase pathways.

3. Prostanoid Receptors: Subtypes and Signaling

4. Prostanoid Receptors

5. Cyclooxygenase Enzymes: Regulation and Function

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of PGE2 on TT cells viability and division;Prostaglandins & Other Lipid Mediators;2024-10

2. The Causal Relationship between Chronic Obstructive Pulmonary Disease and Arterial Thrombotic Diseases: Role of Systemic Inflammation and NF- κB/COX-2 Pathway;2024-06-17

3. Design of Dual EP2/EP4 Antagonists through Scaffold Merging of Selective Inhibitors;ChemMedChem;2023-12-06

4. The Causal Relationship between Chronic Obstructive Pulmonary Disease and Cardiovascular Diseases: Role of Systemic Inflammation and NF-κB/COX-2 Pathway;2023-11-21

5. Targeting EP2 Receptor for Drug Discovery: Strengths, Weaknesses, Opportunities, and Threats (SWOT) Analysis;Journal of Medicinal Chemistry;2023-07-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3